ѪҺg(sh)
W(xu),R̎
ѪҺg(sh)
ѪҺѪԼѪC(j)ϵK˼ϲƼҪоog(sh)?yn)ίһЩѪԼƢгg(sh)g(sh)gl(f)ѪҺog(sh)һЩyҪΣU(xin)dzѪ
| |
| D1 Ѫġٲӡ(yng) |
һһֹѪ^
(һ)wֹѪC(j) ֹѪ^ҪѪܱѪС弰13NѪӡ(dng)ë(x)Ѫѕr(sh)һͨ^(jng)ʹP(gun)СѪտsѪ׃ֹѪһѪƓpr(sh)zԭ¶ѪСճۼጷųADP()Iء5-HT(5-uɫ)ʹѪСپۼγѪСĶֹѪr(sh)g2-4犡cͬr(sh)(ni)ԴcԴѪϵy(tng)ѪӢ(wn)()ѪøѪøąc£wSԭɞwS@r(sh)γɱ^õѪKr(sh)gs1-2Сr(sh)
()ѪC(j) ȡQ13NѪӅӵijʡٲӡøķ(yng)
1ѪҊ1
2Ѫ^ơٲӡ(yng)(D1)ʽ(c)(ni)Դͨ·(intrinsic pathway)ȱ(ni)ԴӱF(xin)PTTʽ҂(c)Դͨ·ȱӱF(xin)PTĮɗlͨ·KwSԭƉġ
()wSܽϵy(tng)(w) rw(ni)вwSײֲܽ⣬ԱѪܵĕͨͬr(sh)w(ni)߀wøcԾSw(ni)wϵy(tng)Ą(dng)B(ti)ƽ
1 Ѫһ[
ͬ x Q | |
| wSԭ(Fibrinogen) | |
| Ѫøԭ(Prothrombin) | |
| MѪ(Tissue thromboplastin) | |
| }(Calcium) | |
| ׃(Labile factor) | |
| (wn)(Stable factor) | |
| ѪѲӼ(Antihemophilia factor,AHF) | |
| ѪѲ(Plasma thromboplastin component,PTC) | |
| ԼѪø(Stuart-Power factor) | |
| Ѫ{Ѫǰ|(zh)(Plasma thromboplastin antecedent,PTA) | |
| |(Hageman factor) | |
| wS(wn)(Fibrin stabilizing factor) |
F(xin)ڲ鿴ժҪȫL(zhng) 11238 ַ